Through gene therapy, researchers engineered blood-forming stem cells (hematopoietic stem/progenitor cells, or HSPCs) to carry chimeric antigen receptor (CAR) genes to make cells that can detect and destroy HIV-infected cells. These engineered cells not only destroyed the infected cells, they persisted for more than two years, suggesting the potential to create long-term immunity from the virus that causes AIDS.
Antiviral drugs can suppress the amount of HIV in the body to nearly undetectable levels, but only an effective immune response can eradicate the virus. Researchers have been seeking a way to improve the body’s ability to combat the virus by engineering blood-forming stem cells to specifically target and kill HIV-infected cells for the life of the individual. Although chimeric antigen receptor (CAR) T-cells have emerged as a powerful immunotherapy for various forms of cancer – and show promise in treating HIV-1 infection – the therapy may not impart long-lasting immunity. Researchers, physicians and patients need T cell-based products that can respond to malignant or infected cells that may reappear months or years after treatment.
Because HIV uses CD4 to infect cells, the researchers used a CAR molecule that hijacks the essential interaction between HIV and the cell surface molecule CD4 to make stem cell-derived T-cells target infected cells. When the CD4 on the CAR molecule binds to HIV, other regions of the CAR molecule signal the cell to become activated and kill the HIV infected cell. The researchers found that, in test animals, modification of the blood-forming stem cells resulted in more than two years of stable production of CAR-expressing cells without any adverse effects. In addition, these cells were widely distributed throughout the lymphoid tissues and gastrointestinal tract, which are major anatomic sites for HIV replication and persistence in infected people. Most important, engineered CAR T-cells showed efficacy in attacking and killing HIV-infected cells.
These findings are the first to show that blood-forming stem cells can be modified with a CAR therapy that can safely engraft in the bone marrow, mature and become functional immune cells throughout the body. This could lead to the development of an approach allowing for safe, lifelong immunity to HIV. Such an approach is likely to work best when performed in combination with other treatment strategies, such as antiretroviral therapy. Researchers hope that this type of therapy could reduce infected individuals’ dependence on antiviral medications, lower the cost of therapy, and permit the possible eradication of HIV from its hiding places in the body. The approach also has potential against other infections or malignancies.
The Latest on: HIV gene therapy
- Gene Editing Startups Cut Fine Therapeutic Figureson December 3, 2020 at 7:57 am
New companies are exploring next-generation CRISPR technologies and powerful CRISPR alternatives to realize new therapeutic approaches.
- Scientists just used CRISPR to cure the simian equivalent of HIV. Here's why this is a big dealon December 2, 2020 at 3:41 pm
That might seem like a head-scratcher: why is HIV, a virus we've known about for decades, so much harder to cure than a virus discovered just last year? Part of the reason is that HIV, as a retrovirus ...
- After decades of work, why don’t we have an HIV vaccine?on December 1, 2020 at 1:54 pm
Medical experts who've long studied the virus behind AIDS believe that our bodies might be the key to eradicating it for good.
- Genetic manipulation: HIV-like virus edited out of primate GENOME in major advance towards winning war on AIDSon December 1, 2020 at 9:46 am
Researchers have made a major breakthrough in treating and possibly eventually curing HIV, by deploying Nobel-prize-winning CRISPR gene editing techniques to purge the virus from the genomes of ...
- Scientists Edit HIV-like Virus Out of Primate Genomeon December 1, 2020 at 8:28 am
SIV, a virus closely related to HIV, the cause of AIDS - from the genomes of non-human primates, has been edited by researchers.
- The Covid-19 vaccines in trial phase has yet to be proven completely safe for pregnant women, HIV positive people and TB patientson December 1, 2020 at 3:57 am
It is yet to be determined if any of the Covid-19 vaccines that are being trialled around the world and in development here in South Africa will in any way negatively impact pregnant women, those on ...
- Researchers successfully edit SIV virus from genomes of non-human primateson November 30, 2020 at 10:19 pm
Taking a major step forward in HIV research, scientists at the Lewis Katz School of Medicine at Temple University have successfully edited SIV - a virus closely related to HIV, the cause of AIDS - ...
- HIV-Like Virus Eliminated from the Genomes of Primates; Excision BioTherapeutics Advancing the Innovation to Clinical Developmenton November 30, 2020 at 12:24 pm
Taking a major step forward in HIV research, scientists at the Lewis Katz School of Medicine at Temple University ...
- HIV-Like Virus Eliminated from the Genomes of Primates; Excision BioTherapeutics Advancing the ...on November 30, 2020 at 11:52 am
Taking a major step forward in HIV research, scientists at the Lewis Katz School of Medicine at Temple University have successfully edited SIV – a virus closely related to HIV, the cause of AIDS – ...
- HIV-like virus edited out of primate genomeon November 30, 2020 at 10:01 am
Taking a major step forward in HIV research, scientists at the Lewis Katz School of Medicine at Temple University have successfully edited SIV—a virus closely related to HIV, the cause of AIDS—from ...
via Google News and Bing News